One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
JAMA Internal Medicine.
doi : 10.1001/jamainternmed.2024.5434
Volume 185(12) pgs. 1406-1514 December 2025
Artificial Intelligence and Clinical Care: JAMA Internal Medicine Call for Papers.
Food Insecurity Interventions to Improve Blood Pressure: The Healthy Food First Factorial Randomized Clinical Trial.
Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial.
Slow-Tempo Music and Delirium/Coma-Free Days Among Older Adults Undergoing Mechanical Ventilation: A Randomized Clinical Trial.
The Potential of Music as a Nonpharmacologic Intervention for the ICU-Sound Medicine.
State Policies and Facility Practices of IV Hydration Spas in the US.
Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial.
Survival Benefits of Deceased Donor Kidney Transplant vs Waitlisting.
Supporting Shared Decision-Making in Life-Altering Kidney Therapy Decisions for Older Adults: A Review.
A Case for Early High-Dose Thiamine-Moving From Reaction to Prevention.
The Harms of Inappropriate Food-Specific Immunoglobulin E Testing-Less Is More.
Higher-Valent Pneumococcal Conjugate Vaccines-Perspective for 2026.
Clinical Obesity and All-Cause and Cause-Specific Mortality in UK Biobank.
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants.
Using the PREVENT Equations to Guide Aspirin Use for Primary Prevention of Cardiovascular Disease.
Hospice Cost-Sharing in the Affordable Care Act Marketplace Individual Plans.
Clinical Cues and Quiet Resistance-Bridging Stewardship Design and Human Decisions.
Pharmacologic Confounders in Steatotic Liver Disease Outcomes Research.
Clinical Cues and Quiet Resistance-Bridging Stewardship Design and Human Decisions-Reply.
Pharmacologic Confounders in Steatotic Liver Disease Outcomes Research-Reply.
Potential Limitations of Low-Dose Methotrexate in Inflammatory Knee Osteoarthritis.
Potential Limitations of Low-Dose Methotrexate in Inflammatory Knee Osteoarthritis-Reply.
